Literature DB >> 21310647

Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study.

Yaroslav Winter1, Sonja von Campenhausen, Martin Arend, Katia Longo, Kai Boetzel, Karla Eggert, Wolfgang H Oertel, Richard Dodel, Paolo Barone.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder with a progressive disabling course. Health-related quality of life (HrQoL) in Italian patients with PD has not been evaluated. The objective of this study was to evaluate HrQol of an Italian cohort of PD patients and to provide a comprehensive analysis of HrQoL determinants. We performed a cross-sectional survey of 70 outpatients with idiopathic PD recruited in the department of Neurology, Napoli University, Italy. Clinical data included the Unified PD Rating Scale (UPDRS), motor and non-motor symptoms. The generic instrument EuroQol (EQ-5D and EQ-VAS) was used to evaluate HrQol. Factors influencing HrQol were assessed by multivariate regression analysis. Severe problems in at least one dimension of the EQ-5D were experienced by 60% of PD patients versus 4.7% in general Italian population. The dimensions most affected were mobility, pain/discomfort and anxiety/depression with only 17.4%, 18.8% and 17.4% of patients, respectively, reporting no problems in these dimensions. The mean EQ-VAS score was 54.20 ± 18.38. Independent determinants of reduced HrQoL were increased UPDRS scores, motor fluctuations, dyskinesias, depression and dementia. PD strongly affects HrQol in Italian patients. The results of this study should be considered in the development of national healthcare programmes aimed at improvement of the HrQoL in Italian patients with PD. In particular, these programmes should concentrate not only on motor but also on non-motor manifestations of PD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21310647     DOI: 10.1016/j.parkreldis.2011.01.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

Review 1.  Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review.

Authors:  Judith Dams; Bernhard Bornschein; Jens Peter Reese; Annette Conrads-Frank; Wolfgang H Oertel; Uwe Siebert; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

2.  Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson's disease.

Authors:  Alberto Raggi; Matilde Leonardi; Venusia Covelli; Alberto Albanese; Paola Soliveri; Francesco Carella; Luigi Romito
Journal:  Neurol Sci       Date:  2011-11-10       Impact factor: 3.307

3.  Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

Authors:  V E Kelly; C O Johnson; E L McGough; A Shumway-Cook; F B Horak; K A Chung; A J Espay; F J Revilla; J Devoto; C Wood-Siverio; S A Factor; B Cholerton; K L Edwards; A L Peterson; J F Quinn; T J Montine; C P Zabetian; J B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-04-14       Impact factor: 4.891

4.  Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2015-06-03       Impact factor: 4.530

Review 5.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

6.  Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.

Authors:  Tanja Stojkovic; Elka Stefanova; Ivan Soldatovic; Vladana Markovic; Iva Stankovic; Igor Petrovic; Federica Agosta; Sebastiano Galantucci; Massimo Filippi; Vladimir Kostic
Journal:  J Neurol       Date:  2018-03-23       Impact factor: 4.849

7.  Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease.

Authors:  Alexander Storch; Kristina Rosqvist; Georg Ebersbach; Per Odin
Journal:  J Neural Transm (Vienna)       Date:  2019-06-19       Impact factor: 3.575

8.  Variables associated with physical health-related quality of life in Parkinson's disease patients presenting for deep brain stimulation.

Authors:  Alexandre Paim Diaz; Fernando Cini Freitas; Maria Emília de Oliveira Thais; Fernando Zanela da Silva Areas; Marcelo Liborio Schwarzbold; Rodrigo Debona; Jean Costa Nunes; Ricardo Guarnieri; Daniel Martinez-Ramirez; Rui Daniel Prediger; Aparna Wagle Shukla; Marcelo Neves Linhares; Roger Walz
Journal:  Neurol Sci       Date:  2016-07-25       Impact factor: 3.307

9.  Longitudinal study of normal cognition in Parkinson disease.

Authors:  Kara Pigott; Jacqueline Rick; Sharon X Xie; Howard Hurtig; Alice Chen-Plotkin; John E Duda; James F Morley; Lama M Chahine; Nabila Dahodwala; Rizwan S Akhtar; Andrew Siderowf; John Q Trojanowski; Daniel Weintraub
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

Review 10.  Understanding, Impact, and Communication of "Off" Periods in Parkinson's Disease: A Scoping Review.

Authors:  Tara Rastgardani; Melissa J Armstrong; Anna R Gagliardi; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.